Celebrity Inventors
Walt Disney was no Mickey Mouse inventor. He devised a serious animation camera which he patented. With the device, his company created "Snow White".
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 5036081 | Calcium absorption promoter Alpha-glucosidase inhibitor is provided as a promoter of calcium absorption in mammals. The examples of the inhibitor are shown by the formula; ##STR1## wherein A stands for a C1 -C10 acyclic hydrocarbon group which may be subst... | 07/30/1991 |
| 5032616 | 4-substituted cyclohexylamine derivatives, fungicides containing these and a method of controlling fungi 4-trans-substituted cyclohexylamine derivatives of the formula ##STR1## where R1 is the group CR5 R6 R7, in which R5, R6 and R7 are hydrogen, unsubstituted or substituted alkyl, ... | 07/16/1991 |
| 4988682 | Myo-inositol analogs and method for their use The present invention relates to a method for inhibiting the phosphatidylinositol cycle in a cell by contacting the cell with certain myo-inositol analogs. Such myo-inositol analogs can also be utilized to treat phosphatidylinositol cycle-dependent condit... | 01/29/1991 |
| 4883805 | Stable, Injectable solutions of vinca dimer salts A stable, injectable pharmaceutical composition of vinca dimer salts. The compositions are in the form of an aqueous solution comprising per 1 ml of solution: from about 0.2 to about 2 mg of one or more pharmaceutically acceptable vinca dimer salts; from ... | 11/28/1989 |
| 4867979 | Antidiarrheal compositions and use thereof Antidiarrheal compositions showing enhanced antidiarrheal activity comprise a non-steroidal anti-inflammatory drug compound and a polymeric hydroabsorptive agent. A patient in need of remedial or preventive treatment of diarrhea symptoms is administered a... | 09/19/1989 |
| 4859709 | Pharmaceutical composition A pharmaceutical composition comprising a freely flowable powder, the powder comprising a porous, high absorption silica or silicate having absorbed therein at least 10% by volume of a liquid, pharmaceutically active composition, based on the weight of po... | 08/22/1989 |
| 4857319 | Method for preserving liposomes A method for preserving liposomes includes freeze-drying liposomes most preferably having an average size of about 50 nm to 100 nm with a disaccharide preserving agent being present both internally (with the encapsulated liposomal contents) and externally... | 08/15/1989 |
| 4847299 | Use of 15-deoxyspergualine as a pharmaceutical The use of 15-deoxyspergualine for the preparation of a pharmaceutical for the therapy of degenerative diseases is claimed.... | 07/11/1989 |
| 4812446 | Pharmaceutical products providing enhanced analgesia An analgesic composition comprising capsaicin or a capsaicin analogue and an analgesic selected from the class of non-steroidal anti-inflammatory, antipyretic and analgesic drugs is disclosed. This combination has been found to exhibit unexpectedly enhanc... | 03/14/1989 |
| 4812449 | In situ active compound assembly Differences in microenvironments associated with various cells and other conditions in this environment are used to advantage in effecting the in situ construction of biologically active agents at target locations in preference to surroundings which are d... | 03/14/1989 |
| 4806354 | Health food composition An improved health food composition comprises; B complex vitamins; a prostaglandin E-1 precursor; a primary emulsifying agent; a flavoring agent; and a preservative. The B complex vitamins include: vitamin B1 (thiamine hydrochloride); vitamin B2 (riboflav... | 02/21/1989 |
| 4789686 | Process for the preparation of an aqueous solution of the sodium salt of methionine A concentrated aqueous solution of the sodium salt of methionine, which is practically free from inorganic salts, is produced from the medium resulting from the hydrolysis of 5-(ଲ-mercaptoethyl)hydantoin.... | 12/06/1988 |
| 4772585 | Protein thrombolytic agent with absorption enhancing agent The absorption rate of protein-thrombolytic agents with medicinal properties in the blood is enhanced by administering the protein intramuscularly together with an absorption enhancing agent, e.g. hydroxylamine or a salt thereof.... | 09/20/1988 |
| 4766151 | Ethers and oxime ethers of alkylamino alcohols as medicaments and novel products, and processes for their preparation Glaucoma can be treated by the application to the eye of a physiologically active amount of a compound of the formula ##STR1## in which: each of R3 and R4 is selected from hydrogen, and alkyl, alkenyl and cycloalkyl radicals, or... | 08/23/1988 |
| 4748022 | Topical composition A composition and method of use for the treatment of pain and inflammation associated with lesions of the skin or mucus membrane, such as herpes simplex, herpes labialis, herpes progenitalis, chickenpox lesions, herpes genitalis, sensitivity of gingival t... | 05/31/1988 |
| 4687662 | Therapeutic effervescent composition Effervescent compositions in the form of tablets or powders comprising a therapeutic agent, a granulating agent, a microparticulate effervescent component and an effervescent system which dissolve rapidly in water to yield an effervescent solution contain... | 08/18/1987 |
| 4661509 | Methods for treating leukopenia A method of improving the levels of formed blood elements in a patient having disease or therapy induced leukopenia comprising administering to said patient a therapeutically effective amount of a pharmaceutically acceptable, water or lipid soluble tertia... | 04/28/1987 |
| 4591605 | Method and ingestible formulation for inhibiting the secretion of stomach acid A method for inhibiting the secretion of stomach acid in vertebrate animals. The method comprises contacting the lumen side of the stomach with a compound which interferes with the acid secretion mechanism yet cannot permeate the lining of the stomach. Th... | 05/27/1986 |
| 4503051 | Substituted 3-cyclobutene-1,2-diones, pharmaceutical compositions thereof and methods of use Compounds of the formula ##STR1## wherein R12 is a leaving group, Z is S, O or CH2 and A is a phenyl, furyl, thienyl or pyridyl ring substituted by a ##STR2## moiety, in which R8 and R9 are various sub... | 03/05/1985 |
| 4374850 | Method of controlling parasitic ticks Certain amines are highly effective in controlling parasitic ticks.... | 02/22/1983 |
| 4325972 | Perfluorinated N,N-dimethyl cyclohexylmethylamine emulsions Benzyl dimethyl amine is subject to electrofluorination in anhydrous HF to produce perfluoro-N,N-dimethylcyclohexylmethylamine. The obtained perfluoro compound is emulsified with the aid of a nonionic surfactant to form a stable emulsion showing promising... | 04/20/1982 |
| 4321271 | Heterocyclic and aliphatic growth promotors Compounds of formula (I) ##STR1## wherein: R1 is C1-6 alkyl or C5-7 cycloalkyl; R2 is hydrogen or C1-6 alkyl; or NR1 R2 represents a heterocyclic ring having 5 to 7 ring atoms an... | 03/23/1982 |
| 4230726 | Control of parasitic mites with alkyl amines Certain secondary and tertiary straight and branched chain amines and amides are found to be highly effective for controlling scabies mites and other parasitic mites.... | 10/28/1980 |
| 4188403 | Cyclopentan-1-amines Compounds of the Formula ##STR1## and the physiologically acceptable salts thereof, wherein R1 and R2 each is hydrogen or benzyl; R3 is alkyl of 5-10 C-atoms or 2-hydroxyalkyl of 5-10 C-atoms; R4 is hydroge... | 02/12/1980 |
| 4087550 | Hydroxylated amine thioethers for improving the greasy and unaesthetic appearance of the hair and skin A method and composition for combatting the greasy and unaesthetic appearance of the hair and to improve the appearance of the skin comprises in a carrier at least one active component of the formula ##STR1## wherein R1 and R2 a... | 05/02/1978 |
| 4076799 | Method of inhibiting skin irritation A method of inhibiting or reducing the irritation of skin resulting from allergic contact dermatitis, caused by contact with natural or synthetic allergenic agents, e.g. poison ivy, and dinitrochlorobenzene, respectively, is described. The method comprise... | 02/28/1978 |
| 3968245 | Sympathomimetic topical and percutaneous administration with halogenated promoters Dermal compositions are disclosed with comprise trichloroethanol or trifluoroethanol as one component of a vehicle having solubilized therein a drug or other beneficial chemical compound. Also disclosed is a method for administering a drug or other benefi... | 07/06/1976 |
| 3962439 | Oxygen-transferable emulsion Oxygen-transferable perfluorocarbon compounds having 9 to 11 carbon atoms such as perfluorodecalin, perfluoro(C3-5 -alkylcyclohexanes), perfluoro(C4-6 -alkyl tetrahydropyrans), perfluoro(C5-7 -alkyltetrahydrofurans), perfl... | 06/08/1976 |
